Skip to main content
Premium Trial:

Request an Annual Quote

UNC Institute to Use InforSense Software for PGx Programs

NEW YORK (GenomeWeb News) - The University of North Carolina at Chapel Hill has licensed InforSense's workflow-based analytics platform for use in pharmacogenomics research projects, the company said yesterday.
 
The Institute of Pharmacogenomics and Individualized Therapy at UNC-CH will use the GenSense software in its efforts to develop "precise, effective treatment options for individual patients suffering from a wide range of conditions," InforSense said.
 
The institute is focused on identifying genetic variants that may predispose patients to severe side effects or poor response to certain drugs.
 
The company said the GenSense software will enable IPIT to "leverage expression data, DNA and micoarray analysis, electronic medical records, and various relational databases to drive its interdisciplinary research initiatives."
 
Financial terms of the agreement were not released.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.